0000000000459782

AUTHOR

S. Soleymani

showing 1 related works from this author

1381P Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month…

2021

Oncologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCheckmateCancerHematologymedicine.diseaseGastroesophageal JunctionOncologyInternal medicineMedicineNivolumabbusinessAdjuvantNeoadjuvant chemoradiotherapyMonth follow upAnnals of Oncology
researchProduct